OBJECTIVES The purpose of this study was to determine the predictors of mortality in patients with pulmonary hypertension (PH) associated with heart failure with preserved ejection fraction (HFpEF).
better discriminated by the diastolic pressure gradient (DPG) with DPG $7 mm Hg and <7 mm Hg to refer to those with combined post-capillary and pre-capillary PH (Comb-PH) and isolated post-capillary PH (Iso-PH), respectively (8) .
Among patients with left ventricular (LV) systolic dysfunction, also referred to as heart failure with reduced ejection fraction (HFrEF), the presence of PH portends a worse prognosis due to right ventricular (RV) failure in the setting of a progressive increase in RV afterload as the LV fails (9, 10) . Recent studies of patients with HFrEF demonstrate that pulmonary arterial capacitance (PAC), the ratio of stroke volume (SV) to pulmonary pulse pressure (PP), is a better determinant of RV afterload and survival than pulmonary vascular resistance (PVR) (11, 12) . Furthermore, in HFrEF, the pulmonary vascular response to acute vasodilators has prognostic significance; the failure of PH to improve and PAWP to normalize during administration of nitroprusside and/or diuretics is associated with a high risk of right heart failure and mortality after cardiac transplantation (13, 14) . The incidence of LV diastolic dysfunction, or heart failure with preserved ejection fraction (HFpEF), is rising and now accounts for one-half of the patients with heart failure (15) . In contrast to those with HFrEF, there is far less information on the role of PH in HFpEF outcomes. Also, the relative utility of the various hemodynamic metrics (TPG, DPG, PVR, and PAC) and that of vasodilator testing, to predict outcomes in HFpEF with PH have not been previously assessed.
Thus, in our cohort of HFpEF patients with PH, we aimed to: 1) determine the prognostic implications of PAC compared to TPG, DPG, PVR, and other hemodynamic parameters in patients with PH-LHD and HFpEF; 2) determine whether the current definition for Comb-PH is associated with a worse survival than PH-LHD with Iso-PH; and 3) evaluate the safety and prognostic value of acute vasodilator testing in PH-LHD and HFpEF.
METHODS
STUDY DESIGN. This is a prospective cohort study of consecutive patients undergoing diagnostic right heart catheterization for suspected PH in the Pulmo- MEASUREMENTS. Demographic data including age, sex, race, height, and weight were recorded. All subjects underwent routine laboratory testing, echocardiography and right heart catheterization. Right heart catheterization was performed in the cardiac catheterization laboratory on patients in the fasting state after minimal sedation at rest and in the supine position. The system was zeroed and referenced at the level of the patient's heart (fourth intercostal space midway between anterior and posterior chest wall). A balloon-tipped thermodilution catheter (Edwards Lifesciences, Irvine, California) was inserted through the internal jugular vein as previously described (16) .
All hemodynamic tracings were reviewed by the operator (N.S.H., I.R.P., or K.E.R.) and pressures were recorded at end-expiration. Cardiac output (CO) was determined in triplicate by the thermodilution technique. PVR was calculated as: (mPAP -PAWP)/ CO. Systemic blood pressure was measured using a digital sphygmomanometer at the time of the right heart catheterization. PAC (ml/mm Hg) and systemic arterial capacitance (SAC) (ml/mm Hg) were calculated using the following equations: PAC ¼ SV/pulmonary PP and SAC ¼ SV/systemic PP.
VASODILATOR TESTING. Vasodilator testing was performed at the discretion of the operator (N.S.H., I.R.P., or K.E.R.). Inhaled nitric oxide (iNO) (Ikaria, Hampton, New Jersey) was administered via an inline system at 20 parts per million for 10 min as previously described (17, 18) . Measurements of PAP, PAWP, and CO were performed after 10 min on iNO. Acute vasodilator response was defined according to the criteria STATISTICAL ANALYSIS. Continuous variables were summarized using means and standard deviations (7) or medians and interquartile range. Categorical variables were summarized using frequencies and pro- Table 1) . As expected, hemodynamic parameters differed between the groups, with Comb-PH patients having higher right atrial pressure, PAWP, mPAP, TPG, and PVR and lower PAC than those with Iso-PH ( Table 2 ). The median follow-up time was 3.6 years (interquartile range: 4.5 years). The cumulative incidence of death during the study period was 34%.
UNIVARIATE AND MULTIVARIATE ANALYSES. Univariate analysis revealed that older age, lower PAC, SAC, body mass index, CO, and pulmonary artery (PA) oxygen saturation, and higher PVR and brain natriuretic peptide, were statistically significantly associated with mortality ( Table 3) . Comb-PH was not significantly associated with greater mortality PAWP ¼ pulmonary artery wedge pressure; PH-LHD ¼ pulmonary hypertension due to left heart disease; RHC ¼ right heart catheterization.
Pulmonary Arterial Capacitance in HFpEF (hazard ratio: 1.15; 95% CI: 0.51 to 2.62; p ¼ 0.73).
After multivariate adjustment in the entire study population, older age and lower PAC were the only independent predictors of mortality ( Table 4) Values are mean AE SD or n (%). *Values in parentheses are the difference between the 25th and 75th percentiles.
Comb-PH ¼ combined post-capillary pulmonary hypertension and pre-capillary pulmonary hypertension; HFpEF ¼ heart failure with preserved ejection fraction; Iso-PH ¼ isolated postcapillary pulmonary hypertension; NYHA ¼ New York Heart Association; PH-LHD ¼ pulmonary hypertension due to left heart disease. Tables 1  and 2 . Figures 1 to 3 ).
Based on clinical expertise and to optimize the potential use of PAC as a screening measure, PAC <1.1 ml/mm Hg was selected to be the optimal cutoff as it was associated with sensitivity >90% and the highest achievable specificity as determined by ROC curves.
Patients with PH-LHD associated with HFpEF and a PAC <1.1 ml/mm Hg had a significantly worse survival than those with PAC $1.1 ml/mm Hg (hazard ratio:
4.9; 95% CI: 1.9 to 12.4; p < 0.001) (Figure 3) . A PAC of <1.1 ml/mm Hg was associated with a sensitivity of 91% (95% CI: 84% to 98%), specificity 38% (95% CI:
27% to 49%), positive predictive value 74% (95% CI:
64% to 84%), and negative predictive value 69% (95% CI: 58% to 80%) in predicting mortality among our patients with HFpEF. Table 5) . As compared with nonresponders, responders were more likely to be female and more obese ( Table 5) Consequently PAC provides a better assessment of RV afterload than either PVR or DPG when PAWP is STUDY LIMITATIONS. The main limitation of our study is our small sample size, which limits our ability to detect possible significant associations between DPG and outcomes. We nonetheless successfully identified several factors that were significantly associated with mortality. We also acknowledge the risk of false positive results in our study given multiple testing and that generated hypotheses will need to be tested in other cohorts. In addition, we should emphasize that this cohort was limited to a referral-based population of HFpEF patients with PH and should not be generalized to those without PH. 
